Evidence map›Paper›PMID 41744859›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Transitioning from Cytology to HPV Test-Based Primary Cervical Screening in Canada: A Population-Based Survey of Women's Screening and Information Preferences.

Ovidiu Tatar, Patricia Zhu, Shannon Salvador, Susie Lau, Jessica Ruel-Laliberté, Samara Perez, Emily McBride, Zeev Rosberger

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ovidiu TatarLady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E1, Canada.ORCID 0000-0003-1886-6390
Patricia ZhuLady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E1, Canada.ORCID 0000-0001-6549-3668
Shannon SalvadorDivision of Gynecologic Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.ORCID 0000-0002-8061-375X
Susie LauDivision of Gynecologic Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
Jessica Ruel-LalibertéDepartment of Obstetrics & Gynecology, Division of Gynecologic Oncology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.ORCID 0000-0002-6108-838X
Samara PerezDepartment of Oncology, McGill University, Montreal, QC H4A 3T2, Canada.ORCID 0000-0002-4849-8616
Emily McBrideInstitute of Psychology, Psychiatry and Neuroscience, King's College London, London SE5 8AF, UK.ORCID 0000-0001-9926-429X
Zeev RosbergerLady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E1, Canada.ORCID 0000-0003-4248-1909

Funding

Canadian Institutes of Health Research (CIHR) 165905
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

best–worst scalingcervical cancereducationhuman papillomavirusinformationpreferencerankingscreeningself-samplingsurvey

Identifiers

PMID41744859
PMCPMC12939021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.